198 related articles for article (PubMed ID: 21567301)
1. Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma.
Steffen-Smith EA; Shih JH; Hipp SJ; Bent R; Warren KE
J Neurooncol; 2011 Nov; 105(2):365-73. PubMed ID: 21567301
[TBL] [Abstract][Full Text] [Related]
2. Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging.
Hipp SJ; Steffen-Smith E; Hammoud D; Shih JH; Bent R; Warren KE
Neuro Oncol; 2011 Aug; 13(8):904-9. PubMed ID: 21757444
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
4. Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma.
Steffen-Smith EA; Venzon DJ; Bent RS; Hipp SJ; Warren KE
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):774-9. PubMed ID: 22445531
[TBL] [Abstract][Full Text] [Related]
5. Discrepant longitudinal volumetric and metabolic evolution of diffuse intrinsic Pontine gliomas during treatment: implications for current response assessment strategies.
Löbel U; Hwang S; Edwards A; Li Y; Li X; Broniscer A; Patay Z
Neuroradiology; 2016 Oct; 58(10):1027-1034. PubMed ID: 27438806
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma.
Yamasaki F; Kurisu K; Kajiwara Y; Watanabe Y; Takayasu T; Akiyama Y; Saito T; Hanaya R; Sugiyama K
Neuro Oncol; 2011 Jul; 13(7):791-801. PubMed ID: 21653595
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
Raizer JJ; Koutcher JA; Abrey LE; Panageas KS; DeAngelis LM; Lis E; Xu S; Zakian KL
J Neurooncol; 2005 Jan; 71(2):173-80. PubMed ID: 15690135
[TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors.
Warren KE; Frank JA; Black JL; Hill RS; Duyn JH; Aikin AA; Lewis BK; Adamson PC; Balis FM
J Clin Oncol; 2000 Mar; 18(5):1020-6. PubMed ID: 10694552
[TBL] [Abstract][Full Text] [Related]
9. Measurements of the pons as a biomarker of progression for pediatric DIPG.
Steffen-Smith EA; Baker EH; Venzon D; Shandilya S; Bent RS; Warren KE
J Neurooncol; 2014 Jan; 116(1):127-33. PubMed ID: 24113877
[TBL] [Abstract][Full Text] [Related]
10. Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria.
Jansen MH; Veldhuijzen van Zanten SE; Sanchez Aliaga E; Heymans MW; Warmuth-Metz M; Hargrave D; van der Hoeven EJ; Gidding CE; de Bont ES; Eshghi OS; Reddingius R; Peeters CM; Schouten-van Meeteren AY; Gooskens RH; Granzen B; Paardekooper GM; Janssens GO; Noske DP; Barkhof F; Kramm CM; Vandertop WP; Kaspers GJ; van Vuurden DG
Neuro Oncol; 2015 Jan; 17(1):160-6. PubMed ID: 24903904
[TBL] [Abstract][Full Text] [Related]
11. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.
Rock JP; Hearshen D; Scarpace L; Croteau D; Gutierrez J; Fisher JL; Rosenblum ML; Mikkelsen T
Neurosurgery; 2002 Oct; 51(4):912-9; discussion 919-20. PubMed ID: 12234397
[TBL] [Abstract][Full Text] [Related]
12. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
13. ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.
Ratai EM; Zhang Z; Fink J; Muzi M; Hanna L; Greco E; Richards T; Kim D; Andronesi OC; Mintz A; Kostakoglu L; Prah M; Ellingson B; Schmainda K; Sorensen G; Barboriak D; Mankoff D; Gerstner ER;
PLoS One; 2018; 13(6):e0198548. PubMed ID: 29902200
[TBL] [Abstract][Full Text] [Related]
14. Temporal pole proton preoperative magnetic resonance spectroscopy in patients undergoing surgery for mesial temporal sclerosis.
Fountas KN; Tsougos I; Gotsis ED; Giannakodimos S; Smith JR; Kapsalaki EZ
Neurosurg Focus; 2012 Mar; 32(3):E3. PubMed ID: 22380857
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance spectroscopy of atypical diffuse pontine masses.
Krieger MD; Blüml S; McComb JG
Neurosurg Focus; 2003 Jul; 15(1):E5. PubMed ID: 15355007
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma.
Heiss JD; Jamshidi A; Shah S; Martin S; Wolters PL; Argersinger DP; Warren KE; Lonser RR
J Neurosurg Pediatr; 2018 Dec; 23(3):333-342. PubMed ID: 30544335
[TBL] [Abstract][Full Text] [Related]
17. Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy.
Guillevin R; Menuel C; Taillibert S; Capelle L; Costalat R; Abud L; Habas C; De Marco G; Hoang-Xuan K; Chiras J; Vallée JN
Br J Cancer; 2011 Jun; 104(12):1854-61. PubMed ID: 21610707
[TBL] [Abstract][Full Text] [Related]
18. Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine glioma.
Sethi R; Allen J; Donahue B; Karajannis M; Gardner S; Wisoff J; Kunnakkat S; Mathew J; Zagzag D; Newman K; Narayana A
J Neurooncol; 2011 Mar; 102(1):121-7. PubMed ID: 20623246
[TBL] [Abstract][Full Text] [Related]
19. Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma.
Broniscer A; Gajjar A; Bhargava R; Langston JW; Heideman R; Jones D; Kun LE; Taylor J
Neurosurgery; 1997 Feb; 40(2):331-7; discussion 337-8. PubMed ID: 9007866
[TBL] [Abstract][Full Text] [Related]
20. Proton MR spectroscopy in neonates with perinatal cerebral hypoxic-ischemic injury: metabolite peak-area ratios, relaxation times, and absolute concentrations.
Cheong JL; Cady EB; Penrice J; Wyatt JS; Cox IJ; Robertson NJ
AJNR Am J Neuroradiol; 2006 Aug; 27(7):1546-54. PubMed ID: 16908578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
